Smit & Van Wyk Patents, Trademarks & Copyright

Granting of a compulsory license for pharmaceuticals

Intellectual Property Attorneys

In the event that an interested person discovers, through what ever means, a patented product that is still in force, and that person wishes to make use of that patent in South Africa, the person may approach the Patentee for the grant of a voluntary license and/or a compulsory license. When it comes to compulsory licensing, the South African Patents Act is largely compliant with the TRIPS Agreement and the Doha Declaration. In particular, section 56 of the South African Patents Act is applicable when applying for such a license, based on a so-called “abuse of rights”. In terms of Section 56, at the request of any interested person, a compulsory license may be granted if one of the following conditions, deemed an abuse of the patent, are met:

  • The patented invention is not being worked in the Republic on a commercial scale or to an adequate extent, after the expiry of a period of four years from the filing date of the patent application or three years from the date of grant of the patent, whichever period expires last, and there is no satisfactory reason therefor (in opinion of Commissioner of Patents).
  • The working of the patented invention does not meet the demand in the Republic to an adequate extent and on reasonable terms.
  • On account of refusal of the Patentee to grant a license on reasonable terms and the establishment or development of trade and industry is being prejudiced and it is in the public interest to grant a licence.
  • The demand in the Republic is being met through importation and the price charged by the Patentee, his licensee or agent for the patented invention is excessive in relation to the price charged therefor in countries where the patented invention is manufactured by, or under licence from, the Patentee. 

Although a Patentee has a Patent Certificate and the exclusive rights to the patented invention for the duration of the patent, a compulsory license may be granted upon request and if one or more of the above requirements have been proven in court.  A compulsory licensee bears the same rights and obligations as any other licensee of the patent, subject to any conditions which may be imposed by the court. The compulsory licence provisions should not be seen as a threat to Patentees. These provisions merely aim to ensure that there is in fact exploitation of patented inventions in South Africa and that patent rights are not exercised in such a manner as to prejudice the development of the relevant industry.  For more information on compulsory licences in South Africa, please contact our Patents Team.

Posted on 17 May, 2021

Home » Intellectual Property Insights » Granting of a compulsory license for pharmaceuticals
Patents, Designs and Trademarks in Africa

File in Africa

Smit & Van Wyk provides a full range of Intellectual Property legal services in all African countries where protection is available. We can provide information on the filing requirements in each of the African countries and can also offer information on the various regional IP organisations such as ARIPO, OAPI and the Madrid protocol. We work with a network of trusted and knowledgeable agents to develop the best possible solution to each of our clients’ needs for trade marks, designs and patents in Africa.

More Articles

African Countries to Invest In

African Countries to Invest In

The African continent is a largely untapped market. With 54 countries and an estimated over 1.366 billion inhabitants (16.72% of the world population), Africa presents a valuable target for small...

Business Development in Africa

Business Development in Africa

Despite the innovation and growth of business development in Africa, a gap remains for foreign goods and services, technology, infrastructure and investment. This makes business in Africa lucrative,...

Intellectual Property, Patents, inventions
Intellectual Property, Designs, Industrial Designs
Intellectual Property, Trademarks, Brand Protection
Intellectual Property, Copyright Protection